| 摘要: |
| 目的 研究贝伐单抗与肿瘤微环境中的巨噬细胞间相互关系,初步探讨临床贝伐单抗治疗肝癌无效的机制。方法 采用免疫组化检测肝癌微环境库否细胞表型。巨噬细胞与肿瘤细胞共培养体系中加入贝伐单抗,采用ELISA方法检测培养体系中炎症因子及血管生长因子的分泌。采用划痕实验检测共培养体系上清对肿瘤细胞迁移的影响。结果 临床标本检测肿瘤微环境中的巨噬细胞为M2型,贝伐单抗显著增加M2型巨噬细胞与肿瘤细胞共培养体系中炎症因子TGFβ、IL-12、IL-10及血管生长因子VEGF的水平,肿瘤细胞迁移显著增加。结论 贝伐单抗激活M2型巨噬细胞,促进炎症因子及血管生长因子分泌,促进肿瘤细胞迁移。 |
| 关键词: 贝伐单抗 M2型巨噬细胞 炎症因子 肿瘤转移 |
| DOI:10.13506/j.cnki.jpr.2016.12.001 |
| 基金项目:南京中医药大学哲学社会科学项目(No.13XZR19);国家自然科学基金重大研究计划集成项目(No.91529304) |
|
|
|
| Bevacizumab promotes cancer metastasis by activating M2 macrophage |
| WANG Zhuo1,LIU Huaiying2 |
| (1.School of Pharmacy,Nanjing University of Chinese Medicine,Nanjing 210023,China;2.Jiangsu Pacific Menoctone Biological Pharmaceutical Co.,Ltd.,Changzhou 213001,China) |
| Abstract: |
| Objective To study the relationship between bevacizumab,macrophages,and tumor cells in the tumor microenvironment,and find the potential mechanism of invalid treatment of bevacizumab in HCC (hepatic cell carcinoma).Methods The phenotype of macrophages in HCC was determined by immunohistochemistry.M2 macrophages and tumor cells were cocultured and bevacizumab was added.The release of inflammatory cytokines and vascular growth factor were detected by ELISA.The impact of supernant from coculture system on tumor cell migration was detected.Results Most macrophages in HCC microenvironment had M2 characteristics.Bevacizumab increased the level of inflammatory cytokines and vascular endothelial growth factor (VEGF) significantly in the M2 macrophages and tumor cells coculture system.Supernant from M2 macrophages and tumor cells coculture system promoted tumor cell migration.Conclusion Bevacizumab can activate M2 macrophage and promote cancer metastasis. |
| Key words: Bevacizumab M2 macrophage Inflammatory cytokines Tumor cell migration |